Rubicon Organics Past Earnings Performance

Past criteria checks 0/6

Rubicon Organics has been growing earnings at an average annual rate of 30.4%, while the Pharmaceuticals industry saw earnings growing at 45.6% annually. Revenues have been growing at an average rate of 43.6% per year.

Key information

30.4%

Earnings growth rate

37.5%

EPS growth rate

Pharmaceuticals Industry Growth23.1%
Revenue growth rate43.6%
Return on equity-5.4%
Net Margin-4.5%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

A Piece Of The Puzzle Missing From Rubicon Organics Inc.'s (CVE:ROMJ) 26% Share Price Climb

Dec 22
A Piece Of The Puzzle Missing From Rubicon Organics Inc.'s (CVE:ROMJ) 26% Share Price Climb

Health Check: How Prudently Does Rubicon Organics (CVE:ROMJ) Use Debt?

Sep 25
Health Check: How Prudently Does Rubicon Organics (CVE:ROMJ) Use Debt?

Rubicon Organics Inc. (CVE:ROMJ) Soars 27% But It's A Story Of Risk Vs Reward

Jun 08
Rubicon Organics Inc. (CVE:ROMJ) Soars 27% But It's A Story Of Risk Vs Reward

Calculating The Fair Value Of Rubicon Organics Inc. (CVE:ROMJ)

May 06
Calculating The Fair Value Of Rubicon Organics Inc. (CVE:ROMJ)

Is Rubicon Organics (CVE:ROMJ) A Risky Investment?

Mar 07
Is Rubicon Organics (CVE:ROMJ) A Risky Investment?

Is Rubicon Organics (CVE:ROMJ) A Risky Investment?

Sep 28
Is Rubicon Organics (CVE:ROMJ) A Risky Investment?

Benign Growth For Rubicon Organics Inc. (CVE:ROMJ) Underpins Stock's 26% Plummet

Jun 13
Benign Growth For Rubicon Organics Inc. (CVE:ROMJ) Underpins Stock's 26% Plummet

Is Rubicon Organics (CVE:ROMJ) Using Too Much Debt?

Jun 06
Is Rubicon Organics (CVE:ROMJ) Using Too Much Debt?

Would Rubicon Organics (CVE:ROMJ) Be Better Off With Less Debt?

Jan 09
Would Rubicon Organics (CVE:ROMJ) Be Better Off With Less Debt?

Here's Why Rubicon Organics (CVE:ROMJ) Can Afford Some Debt

Sep 19
Here's Why Rubicon Organics (CVE:ROMJ) Can Afford Some Debt

What Type Of Shareholders Own The Most Number of Rubicon Organics Inc. (CSE:ROMJ) Shares?

Jul 29
What Type Of Shareholders Own The Most Number of Rubicon Organics Inc. (CSE:ROMJ) Shares?

Revenue & Expenses Breakdown

How Rubicon Organics makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TSXV:ROMJ Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2444-2150
30 Jun 2441-3140
31 Mar 2440-3150
31 Dec 2340-2140
30 Sep 2341-5160
30 Jun 2342-2160
31 Mar 2339-3160
31 Dec 2236-4160
30 Sep 2231-2150
30 Jun 2228-8140
31 Mar 2224-12150
31 Dec 2123-15150
30 Sep 2121-18150
30 Jun 2117-18150
31 Mar 2113-15130
31 Dec 209-14120
30 Sep 205-12110
30 Jun 201-11100
31 Mar 200-12110
31 Dec 190-11110
30 Sep 19-1-9100
30 Jun 19-1-10110
31 Mar 190-25100
31 Dec 180-2590
30 Sep 182-2690
30 Jun 181-2360
31 Mar 181-870
31 Dec 171-650
31 Dec 162200

Quality Earnings: ROMJ is currently unprofitable.

Growing Profit Margin: ROMJ is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ROMJ is unprofitable, but has reduced losses over the past 5 years at a rate of 30.4% per year.

Accelerating Growth: Unable to compare ROMJ's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ROMJ is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-51.1%).


Return on Equity

High ROE: ROMJ has a negative Return on Equity (-5.43%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 04:21
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Rubicon Organics Inc. is covered by 6 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kimberly Thompson-HedlinCanaccord Genuity
John ChuDesjardins Securities Inc.
Colin HealeyHaywood Securities Inc.